肺炎検査市場：タイプ、方法、技術、エンドユーザー別-2025-2030年の世界予測

肺炎検査市場は、2023年に14億9,000万米ドルと評価され、2024年には15億8,000万米ドルに達すると予測され、CAGR 6.23％で成長し、2030年には22億8,000万米ドルに達すると予測されています。

肺炎検査には、胸部X線のような画像診断技術、喀痰培養のような臨床検査、細菌やウイルス病原体を検出するPCRのような迅速分子アッセイなど、肺炎を特定するために使用されるさまざまな診断方法が含まれています。肺炎検査の必要性は、適切な治療戦略を開始し、感染拡大を抑え、この呼吸器疾患に関連する死亡率を低下させるために、迅速かつ正確な診断が必要であることにあります。調査用途は、病院、外来診療所、診断研究所で、最終用途はヘルスケアプロバイダー、公衆衛生機関、研究機関などです。肺炎検査市場を牽引する主な成長要因としては、世界の肺炎罹患率の上昇、感染症に対する意識の高まり、診断方法の技術的進歩、医療診断における人工知能の統合などが挙げられます。特に資源に制約のある環境では、早期発見とリアルタイムの意思決定を強化するポイント・オブ・ケア検査の需要拡大に大きな機会があります。しかし、高度な診断ツールの高価格、規制上のハードル、検査感度や特異度のばらつきによる偽結果の可能性などの課題が、市場の成長を制限する可能性があります。さらに、抗生物質耐性菌の出現は、診断精度の向上と迅速な検査機能の必要性を強調しています。イノベーションの焦点は、病原体検出のためのCRISPR技術の統合やバイオセンサー技術の強化など、高精度と簡便性を兼ね備えた費用対効果の高い携帯型検査機器の開発かもしれないです。ハイテク企業とヘルスケア・プロバイダーとのコラボレーションによって、さらなる進歩がもたらされる可能性があります。肺炎検査市場は、技術革新の継続と現在の限界に対処する戦略的イニシアチブを条件として、ダイナミックかつ大幅な成長の態勢を整えています。これらの課題に包括的に取り組み、新たな機会を活用することは、肺炎診断薬市場における競争優位性を維持し、市場での地位向上を目指す企業にとって不可欠です。

市場力学：急速に進化する肺炎検査市場の主要市場インサイトを公開

肺炎検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の老人人口の増加に伴う肺炎の有病率の増加
  • 肺炎に対する認識を高めるためのヘルスケア組織によるイニシアチブの利用可能性
  • 肺炎のポイントオブケア検査（POCT）への関心の高まり
• 市場抑制要因
  • 包括的な肺炎検査の高コスト
• 市場機会
  • 肺炎に対する高度で迅速かつ正確な診断検査の開発の増加
  • 革新的なバイオマーカーに基づく検査の可能性の拡大
• 市場の課題
  • 資源が限られた環境における検査へのアクセス制限

ポーターの5つの力：肺炎検査市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：肺炎検査市場における外部からの影響の把握

外部マクロ環境要因は、肺炎検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析肺炎検査市場における競合情勢の把握

肺炎検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス肺炎検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、肺炎検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨肺炎検査市場における成功への道筋を描く

肺炎検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で高齢者人口の増加に伴い肺炎の罹患率が増加
    • 肺炎に関する意識を高めるためのヘルスケア機関による取り組みの有無
    • 肺炎のポイントオブケア検査（POCT）への傾向の高まり
  • 抑制要因
    • 包括的な肺炎検査の高コスト
  • 機会
    • 肺炎の高度で迅速かつ正確な診断検査の開発が進む
    • 革新的なバイオマーカーベースの検査の可能性の拡大
  • 課題
    • リソースが限られた環境での検査へのアクセスが制限される
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 肺炎検査市場：タイプ別

• 機器
• 試薬・消耗品

第7章 肺炎検査市場：方法別

• 免疫診断
• 分子診断
• ポイントオブケア検査

第8章 肺炎検査市場：技術別

• 酵素免疫測定法
• 免疫蛍光法
• 免疫組織化学
• ポリメラーゼ連鎖反応
• ウエスタンブロット

第9章 肺炎検査市場：エンドユーザー別

• 診断検査室
• 病院・クリニック

第10章 南北アメリカの肺炎検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の肺炎検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの肺炎検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Curetis GmbH
• Danaher Corporation
• DiaSorin S.p.A.
• Eurofins Scientific SE
• F. Hoffmann-La Roche Ltd
• Hain Lifescience GmbH by Bruker Corporation
• Hologic, Inc.
• Intec Products, Inc.
• Luminex Corporation
• Meridian Bioscience, Inc.
• OpGen Inc.
• QIAGEN N.V.
• Quest Diagnostics Incorporated
• Quidel Corporation
• Sekisui Diagnostics, LLC
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• Trinity Biotech PLC
• True Bearing Diagnostics, Inc.

LIST OF FIGURES

• FIGURE 1. PNEUMONIA TESTING MARKET RESEARCH PROCESS
• FIGURE 2. PNEUMONIA TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PNEUMONIA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. PNEUMONIA TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. PNEUMONIA TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PNEUMONIA TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PNEUMONIA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PNEUMONIA TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. CANADA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. CANADA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 38. CANADA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. CANADA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. CHINA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. CHINA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 60. CHINA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. CHINA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. INDIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. INDIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 64. INDIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. INDIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. ITALY PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. ITALY PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 133. ITALY PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. ITALY PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. POLAND PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. POLAND PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 149. POLAND PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 150. POLAND PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. QATAR PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. QATAR PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 153. QATAR PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. QATAR PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. PNEUMONIA TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 192. PNEUMONIA TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Pneumonia Testing Market was valued at USD 1.49 billion in 2023, expected to reach USD 1.58 billion in 2024, and is projected to grow at a CAGR of 6.23%, to USD 2.28 billion by 2030.

Pneumonia testing encompasses various diagnostic methods used to identify pneumonia, including imaging techniques like chest X-rays, laboratory tests like sputum cultures, and rapid molecular assays like PCR to detect bacterial and viral pathogens. The necessity of pneumonia testing is driven by the need for prompt and accurate diagnosis to initiate appropriate treatment strategies, reduce infection spread, and lower mortality rates associated with this respiratory condition. Applications are found across hospitals, outpatient clinics, and diagnostic laboratories, with end-use sectors including healthcare providers, public health organizations, and research institutions. Key growth factors driving the pneumonia testing market include the rising incidence of pneumonia globally, increased awareness about infectious diseases, technological advancements in diagnostic methods, and the integration of artificial intelligence in medical diagnostics. A significant opportunity lies in the expanding demand for point-of-care testing that enhances early detection and real-time decision-making, particularly in resource-constrained settings. However, challenges such as the high cost of advanced diagnostic tools, regulatory hurdles, and the potential for false results due to variability in test sensitivity and specificity can limit market growth. Additionally, emerging antibiotic-resistant strains of bacteria underscore the need for improved diagnostic accuracy and rapid testing capabilities. Innovations may focus on developing cost-effective, portable testing devices that combine high accuracy with simplicity, such as integrating CRISPR technology for pathogen detection or enhancing biosensor technology. Collaborations between tech firms and healthcare providers could unlock further advancements. The market for pneumonia testing is dynamic and poised for substantial growth, contingent on continued technological innovation and strategic initiatives that address current limitations. Comprehensively tackling these challenges and leveraging emerging opportunities will be vital for companies aiming to maintain competitive advantage and enhance market position in pneumonia diagnostics.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pneumonia Testing Market

The Pneumonia Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of pneumonia with expanding geriatric population worldwide
  • Availability of initiatives by healthcare organizations to raise awareness about pneumonia
  • Growing inclination towards point-of-care testing (POCT) for pneumonia
• Market Restraints
  • High cost of comprehensive pneumonia testing
• Market Opportunities
  • Increasing development of advanced rapid and accurate diagnostic tests for pneumonia
  • Expanding potential for innovative biomarker-based tests
• Market Challenges
  • Limited access to testing in resource-limited settings

Porter's Five Forces: A Strategic Tool for Navigating the Pneumonia Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pneumonia Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pneumonia Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pneumonia Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pneumonia Testing Market

A detailed market share analysis in the Pneumonia Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pneumonia Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pneumonia Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pneumonia Testing Market

A strategic analysis of the Pneumonia Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pneumonia Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Curetis GmbH, Danaher Corporation, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Hain Lifescience GmbH by Bruker Corporation, Hologic, Inc., Intec Products, Inc., Luminex Corporation, Meridian Bioscience, Inc., OpGen Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Quidel Corporation, Sekisui Diagnostics, LLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and True Bearing Diagnostics, Inc..

Market Segmentation & Coverage

This research report categorizes the Pneumonia Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Instruments and Reagents & Consumables.
• Based on Method, market is studied across Immunodiagnostics, Molecular Diagnostics, and Point of Care Testing.
• Based on Technology, market is studied across Enzyme Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry, Polymerase Chain Reaction, and Western Blot.
• Based on End-user, market is studied across Diagnostic Laboratories and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of pneumonia with expanding geriatric population worldwide
    • 5.1.1.2. Availability of initiatives by healthcare organizations to raise awareness about pneumonia
    • 5.1.1.3. Growing inclination towards point-of-care testing (POCT) for pneumonia
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of comprehensive pneumonia testing
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing development of advanced rapid and accurate diagnostic tests for pneumonia
    • 5.1.3.2. Expanding potential for innovative biomarker-based tests
  • 5.1.4. Challenges
    • 5.1.4.1. Limited access to testing in resource-limited settings
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pneumonia Testing Market, by Type

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Reagents & Consumables

7. Pneumonia Testing Market, by Method

• 7.1. Introduction
• 7.2. Immunodiagnostics
• 7.3. Molecular Diagnostics
• 7.4. Point of Care Testing

8. Pneumonia Testing Market, by Technology

• 8.1. Introduction
• 8.2. Enzyme Linked Immunosorbent Assay
• 8.3. Immunofluorescence
• 8.4. Immunohistochemistry
• 8.5. Polymerase Chain Reaction
• 8.6. Western Blot

9. Pneumonia Testing Market, by End-user

• 9.1. Introduction
• 9.2. Diagnostic Laboratories
• 9.3. Hospitals & Clinics

10. Americas Pneumonia Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Pneumonia Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Pneumonia Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Becton, Dickinson and Company
• 3. Bio-Rad Laboratories, Inc.
• 4. bioMerieux SA
• 5. Curetis GmbH
• 6. Danaher Corporation
• 7. DiaSorin S.p.A.
• 8. Eurofins Scientific SE
• 9. F. Hoffmann-La Roche Ltd
• 10. Hain Lifescience GmbH by Bruker Corporation
• 11. Hologic, Inc.
• 12. Intec Products, Inc.
• 13. Luminex Corporation
• 14. Meridian Bioscience, Inc.
• 15. OpGen Inc.
• 16. QIAGEN N.V.
• 17. Quest Diagnostics Incorporated
• 18. Quidel Corporation
• 19. Sekisui Diagnostics, LLC
• 20. Siemens Healthineers AG
• 21. Thermo Fisher Scientific Inc.
• 22. Trinity Biotech PLC
• 23. True Bearing Diagnostics, Inc.